Market Forecast By Application (Analgesic, Opioid Antagonist), By Route of Administration (Injectables, Sublingual, Transdermal Patches), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And Competitive Landscape
Product Code: ETC417028 | Publication Date: Oct 2022 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Bangladesh Buprenorphine Market is expected to grow during the upcoming years. Buprenorphine is a medication used to treat opioid addiction. It is a partial agonist of the mu-opioid receptor, which means that it produces some of the same effects as opioids but with less intensity. Buprenorphine can be used to help people reduce their use of opioids or to help them detox from opioids. It is also used to manage pain.
According to 6Wresearch, the Bangladesh Buprenorphine Market size is expected to grow during 2022-2028. Buprenorphine is available as an injection or as a sublingual tablet. The injection is given under the skin, into a muscle, or into a vein. The sublingual tablet is placed under the tongue and dissolved. Buprenorphine can cause side effects including dizziness, headache, nausea, vomiting, drowsiness, dry mouth, sweating, and constipation. It can also cause low blood pressure and slow heart rate. More serious side effects include seizures, slowed breathing, and death.
Buprenorphine should not be used by people who are allergic to it or who have certain medical conditions such as severe asthma or breathing problems, liver disease, or kidney disease. It should also be used with caution in people who have mental health disorders such as depression or bipolar disorder.
Buprenorphine is a partial opioid agonist that binds to the mu-opioid receptor in the brain and spinal cord. This action produces a milder form of opioid analgesia than full agonists such as heroin and methadone. Buprenorphine also reverses the respiratory depression caused by other opioids. The combination of these effects makes buprenorphine an effective treatment for pain relief and opioid dependence.
The Bangladesh Buprenorphine Market is expected to grow during the forecast period. The major factors driving the growth of the market are:
Increasing prevalence of opioid addiction: According to a report by the World Health Organization (WHO), the global prevalence of opioid addiction is estimated to be around 0.6% of the population. Bangladesh has a high burden of drug addiction. This number is expected to grow in the coming years, due to factors such as poverty, unemployment, and social exclusion.
Government initiatives to tackle drug addiction: The Government of Bangladesh is taking various initiatives to address the problem of drug addiction in the country. These include creating awareness about drug addiction and its harmful effects, strengthening law enforcement to curb illegal drug trade, and providing treatment and rehabilitation services for addicts.
Growing medical tourism in Bangladesh: Bangladesh is a popular destination for medical tourism due to its affordable healthcare services. This is expected to boost the demand for buprenorphine market in Bangladesh, as it is used for treating pain and withdrawal symptoms associated with opioid addiction.
Favorable reimbursement policies: In Bangladesh, buprenorphine is included in the list of essential medicines by the Ministry of Health and Family Welfare. This makes it easier for patients to access this medication and also receive reimbursement from their health insurance providers.
Increasing number of clinical trials: Buprenorphine is being investigated for its potential use in various other indications such as chronic pain, postoperative pain, and cancer pain. This is expected to create new opportunities for the growth of the market in the coming years.
The top three companies currently involved in the Bangladesh Buprenorphine Market are Reckitt Benckiser, GlaxoSmithKline and Pfizer.
Reckitt Benckiser is a British multinational consumer goods company headquartered in Slough, Berkshire. It is a producer of health, hygiene and home products. The company has a wide range of products which include air fresheners, laundry detergents, dishwashing liquids, etc. It also has a presence in the buprenorphine market through its product Nurofen Plus.
GlaxoSmithKline is a British pharmaceutical company headquartered in Brentford, London. It was formed by the merger of Glaxo Wellcome and SmithKline Beecham in 2000. The company has a wide range of products which include vaccines, over-the-counter medicines and prescription drugs. It also has a presence in the buprenorphine market through its product Suboxone.
Pfizer is an American pharmaceutical company headquartered in New York City. It is one of the world's largest pharmaceutical companies. The company has a wide range of products which include biopharmaceuticals, vaccines and small molecule drugs. It also has a presence in the buprenorphine market through its product Subutex.
The outburst of coronavirus pandemic has negatively declined the growth of almost every market. The private healthcare sector also suffered a major decline due to the financial status. Moreover, the lockdown imposed by the government hampered the supply chain of the product.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bangladesh Buprenorphine Market Overview |
3.1 Bangladesh Country Macro Economic Indicators |
3.2 Bangladesh Buprenorphine Market Revenues & Volume, 2021 & 2028F |
3.3 Bangladesh Buprenorphine Market - Industry Life Cycle |
3.4 Bangladesh Buprenorphine Market - Porter's Five Forces |
3.5 Bangladesh Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2028F |
3.6 Bangladesh Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2028F |
3.7 Bangladesh Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2028F |
4 Bangladesh Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Bangladesh Buprenorphine Market Trends |
6 Bangladesh Buprenorphine Market, By Types |
6.1 Bangladesh Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Bangladesh Buprenorphine Market Revenues & Volume, By Application, 2018 - 2028F |
6.1.3 Bangladesh Buprenorphine Market Revenues & Volume, By Analgesic, 2018 - 2028F |
6.1.4 Bangladesh Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2018 - 2028F |
6.2 Bangladesh Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Bangladesh Buprenorphine Market Revenues & Volume, By Injectables, 2018 - 2028F |
6.2.3 Bangladesh Buprenorphine Market Revenues & Volume, By Sublingual, 2018 - 2028F |
6.2.4 Bangladesh Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2018 - 2028F |
6.3 Bangladesh Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Bangladesh Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2028F |
6.3.3 Bangladesh Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2018 - 2028F |
6.3.4 Bangladesh Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2018 - 2028F |
7 Bangladesh Buprenorphine Market Import-Export Trade Statistics |
7.1 Bangladesh Buprenorphine Market Export to Major Countries |
7.2 Bangladesh Buprenorphine Market Imports from Major Countries |
8 Bangladesh Buprenorphine Market Key Performance Indicators |
9 Bangladesh Buprenorphine Market - Opportunity Assessment |
9.1 Bangladesh Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2028F |
9.2 Bangladesh Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2028F |
9.3 Bangladesh Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2028F |
10 Bangladesh Buprenorphine Market - Competitive Landscape |
10.1 Bangladesh Buprenorphine Market Revenue Share, By Companies, 2021 |
10.2 Bangladesh Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |